Company Profile
Lifevantage Stock Price, News & Analysis
Company overview
Business overview
Lifevantage is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Lifevantage is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Lifevantage follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Lifevantage sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Why the stock is moving
LFVN is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
LifeVantage’s catalysts are product sales, distributor activity, and margin discipline in consumer wellness. The company improves when its recurring consumer base stays healthy.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026
Source: Lifevantage
- 02
- 03
- 04
LifeVantage Declares Quarterly Dividend
Source: Lifevantage
- 05
LifeVantage to Participate in the Sidoti Small Cap Conference
Source: Lifevantage
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.